Fulltext

Inhibition of Angiogenesis and Nitric Oxide Synthase (NOS), by Embelin & Vilangin Using in vitro, in vivo & in Silico Studies

Narayanaswamy R 1 , Shymatak M 2 , Chatterjee S 2 , Wai LK 3 , Arumugam G 4

Affiliations 

  • 1 Microbiology Division, Central Leather Research Institute (CLRI), Chennai, India. ; Laboratory of Natural Products, Institute of Bioscience (IBS), Universiti Putra Malaysia (UPM), Serdang, Selangor, Malaysia
  • 2 Vascular Biology Laboratory, AU-KBC Research Centre, Anna University, Chennai, India
  • 3 Faculty of Pharmacy, Universiti Kebangsaan Malaysia (UKM), Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia
  • 4 Microbiology Division, Central Leather Research Institute (CLRI), Chennai, India
Adv Pharm Bull, 2014 Dec;4(Suppl 2):543-8.
PMID: 25671187 DOI: 10.5681/apb.2014.080

Abstract

In recent year's anti-angiogenesis agents have been recognized as effective drugs for the treatment of solid tumors, this prompted us to conduct the present study.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications